Cite
Cyclophosphamide/fludarabine/rituximab: Agranulocytosis: case report.
MLA
“Cyclophosphamide/Fludarabine/Rituximab: Agranulocytosis: Case Report.” Reactions Weekly, vol. 1932, no. 1, Nov. 2022, p. 220. EBSCOhost, https://doi.org/10.1007/s40278-022-27585-9.
APA
Cyclophosphamide/fludarabine/rituximab: Agranulocytosis: case report. (2022). Reactions Weekly, 1932(1), 220. https://doi.org/10.1007/s40278-022-27585-9
Chicago
“Cyclophosphamide/Fludarabine/Rituximab: Agranulocytosis: Case Report.” 2022. Reactions Weekly 1932 (1): 220. doi:10.1007/s40278-022-27585-9.